FDA Label for aripiprazole and CYP2D6 - PharmGKB Aripiprazole Brand Name: Abilify, Abilify Discmelt Overview Abilify is the brand name for aripiprazole, a new atypical antipsychotic that was FDA approved in November 2002. The FDA-approved drug label for aripiprazole states that in CYP2D6 poor. will increase ABILIFY drug concentrations; reduce ABILIFY dose to.
Abilify Dosage - Bipolar Disorder Home Page Abilify is chemiy different from other atypical antipsychotic medications such as Clozaril, Geodon, and Risperdal. The recommended starting Abilify dosage for people with bipolar disorder is 15 mg a day. This eMedTV segment also offers dosing guidelines for the treatment of.
ABILIFY® aripiprazole Schizophrenia in Adults Dosing Aripiprazole may be given by injection into a muscle (intramuscularly) if there is a need for rapid control of agitation and disturbed behaviour in people with schizophrenia, or manic episodes in people with bipolar disorder. Dosing for Adult Patients with Schizophrenia. ABILIFY should be written for the smallest dose consistent with good patient management to reduce the risk of.
ABILIFY® aripiprazole Bipolar I Disorder Pediatric Dosing The FDA-approved drug label for aripiprazole states that in CYP2D6 poor metabolizers, the dose should be reduced to 50% of the usual dose then adjusted to receive a favorable clinical response. Dosing for Pediatric Patients with Bipolar I Disorder, Manic or Mixed. In pediatric. will decrease ABILIFY drug concentrations; double ABILIFY dose when used.
Aripiprazole dose and aripiprazole side effects Patient Acute and maintenance treatment of manic or mixed episodes in bipolar I disorder as monotherapy; or as an adjunct to lithium or valproate. Caution with drugs that interfere with temperature regulation (eg, anticholinergics). Levels may be reduced by CYP3A4 inducers (eg, carbamazepine). Stopping aripiprazole suddenly can cause problems so your doctor may want you to reduce your dose gradually if this becomes necessary.